The effects of Nordic walking on a high-molecular weight adiponectin: Randomized controlled study.

在这项研究中，51名肥胖老年人被随机分为北欧步行组（NW）和常规步行组（RW）。两组参与者在24周内每周进行一次锻炼。在24周运动干预前后评估心血管疾病的危险因素，如高分子量脂联素（HM-AD）水平，并检查干预效果。运动干预后，体重和内脏脂肪面积（VFA）下降，NW组的结果明显好于RW组（体重，-4.2+/- 0.5 vs -2.8 +/- 0.4 kg； VFA,-42.5 +/- 6.0 vs -22.6 +/- 6.9 cm2）。干预后RW组血液中HM-AD水平明显升高。但组间差异不显著。很明显，NW是一种有效的运动疗法，可以降低肥胖老年人患心血管疾病的风险。

In this study, 51 obese elderly subjects were randomized into either a Nordic walking group (NW) or a regular walking group (RW). Participants in both groups underwent an exercise program once a week for 24 weeks. Risk factors for cardiovascular disease, such as high-molecular weight adiponectin (HM-AD) level, were assessed before and after the 24-week exercise intervention, and the effects of intervention were examined.Weight and visceral fat area (VFA) decreased in response to exercise intervention, and the results were significantly better in the NW group than in the RW group (weight,-4.2+/- 0.5 vs. -2.8 +/- 0.4 kg; VFA,-42.5 +/- 6.0 vs. -22.6 +/- 6.9 cm2). HM-AD level in the blood increased significantly in the RW group after intervention. However, the between-group difference was not significant. It is clear that NW can be an effective exercise therapy to decrease the risk of cardiovascular disease among obese elderly individuals.